Reading about the current state of laparoscopic radical prostatectomy related by one of its pioneers may give the impression that this procedure is relatively easy to perform in most patients with prostate cancer (see article, page 1). But it is important to realize that Claude Abbou, MD; Bertrand Guillonneau, MD; Guy Vallencien, MD; and others now have a large clinical experience with the procedure that did not occur overnight. I have been awed by the dedication shown by these French urologists in developing and refining what might be considered the "Mount Everest" of minimally invasive surgery.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.